Gain Therapeutics
(NASDAQ:GANX)
4.13
-0.07[-1.67%]
Last update: 10:24AM
15 minutes delayed
Day High/Low4.04 - 4.2
52 Week High/Low2.33 - 10.77
Open / Close4.2 / -
Float / Outstanding10.8M / 11.9M
Vol / Avg.6.6K / 164.7K
Mkt Cap49.1M
P/E-
50d Avg. Price3.3
Div / Yield-
Payout Ratio-
EPS-0.26
Total Float10.8M

Gain Therapeutics (NASDAQ:GANX), Quotes and News Summary

Gain Therapeutics (NASDAQ: GANX)

Day High/Low4.04 - 4.2
52 Week High/Low2.33 - 10.77
Open / Close4.2 / -
Float / Outstanding10.8M / 11.9M
Vol / Avg.6.6K / 164.7K
Mkt Cap49.1M
P/E-
50d Avg. Price3.3
Div / Yield-
Payout Ratio-
EPS-0.26
Total Float10.8M
load more
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-0.370-0.280 0.0900
REV40.000K45.000K5.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Gain Therapeutics Questions & Answers

Q
How do I buy Gain Therapeutics (GANX) stock?
A

You can purchase shares of Gain Therapeutics (NASDAQ: GANX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Gain Therapeutics's (GANX) competitors?
A

There are no as such competitors for Gain Therapeutics.

Q
What is the target price for Gain Therapeutics (GANX) stock?
A

The latest price target for Gain Therapeutics (NASDAQ: GANX) was reported by B. Riley Securities on Tuesday, March 29, 2022. The analyst firm set a price target for 16.00 expecting GANX to rise to within 12 months (a possible 287.41% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Gain Therapeutics (GANX)?
A

The stock price for Gain Therapeutics (NASDAQ: GANX) is $4.13 last updated Today at June 28, 2022, 2:24 PM UTC.

Q
Does Gain Therapeutics (GANX) pay a dividend?
A

There are no upcoming dividends for Gain Therapeutics.

Q
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
A

Gain Therapeutics’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is Gain Therapeutics (GANX) going to split?
A

There is no upcoming split for Gain Therapeutics.

Q
What sector and industry does Gain Therapeutics (GANX) operate in?
A

Gain Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.